An ever-increasing demand for novel antimicrobials to treat life-threatening infections caused by the global spread of multidrug-resistant bacterial pathogens stands in stark …
Background We assessed the impact of the coronavirus disease 2019 (COVID-19) epidemic in India on the consumption of antibiotics and hydroxychloroquine (HCQ) in the private …
Introduction Since the onset of the pandemic, prescribing antimicrobials has become a common practice to treat patients infected with COVID-19. Areas covered A systematic …
CJ Clancy, IS Schwartz, B Kula… - Open Forum Infectious …, 2021 - academic.oup.com
Background Limited clinical data suggest a~ 16% prevalence of bacterial superinfections among critically ill patients with coronavirus disease 2019 (COVID-19). Methods We …
J Rodríguez-Baño, GM Rossolini… - Transactions of the …, 2021 - academic.oup.com
Antibiotic use in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients during the COVID-19 pandemic has exceeded the incidence of bacterial coinfections and …
The net effect of the coronavirus disease 2019 (COVID-19) pandemic and the response to it on the emergence of antimicrobial resistance is yet unknown. Positive impacts on the spread …
RRS Hussein, MB Shaman, AH Shaaban… - The Journal of Infection …, 2022 - jidc.org
Abstract Introduction: Coronavirus disease 2019 (COVID-19) results in similar clinical characteristics as bacterial respiratory tract infections and can potentially lead to antibiotic …
The rapid emergence and spread of antimicrobial resistance continue to kill an estimated 700,000 people annually, and this number is projected to increase ten-fold by 2050. With the …
S Grau, S Hernandez, D Echeverria-Esnal… - Antibiotics, 2021 - mdpi.com
Background: Antimicrobials have been widely used during the COVID-19 pandemic. This study aimed to analyze the impact of the COVID-19 pandemic on the antimicrobial …